Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct

BackgroundDespite the development of a new class of antiemetics, postoperative nausea and vomiting (PONV) still remains a frequent and distressing complication. We compared the prophylactic antiemetic effect of administering dexamethasone 5 mg as an adjunct to ramosetron and ondansetron in patients...

Full description

Bibliographic Details
Main Authors: Yong Seon Choi, Jae-Kwang Shim, Seung-Ho Ahn, Young Lan Kwak
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2012-06-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kjae-62-543.pdf
_version_ 1818324913667178496
author Yong Seon Choi
Jae-Kwang Shim
Seung-Ho Ahn
Young Lan Kwak
author_facet Yong Seon Choi
Jae-Kwang Shim
Seung-Ho Ahn
Young Lan Kwak
author_sort Yong Seon Choi
collection DOAJ
description BackgroundDespite the development of a new class of antiemetics, postoperative nausea and vomiting (PONV) still remains a frequent and distressing complication. We compared the prophylactic antiemetic effect of administering dexamethasone 5 mg as an adjunct to ramosetron and ondansetron in patients at high-risk for PONV following lumbar spinal surgery.MethodsIn this randomized, double-blind study, 120 female non-smoking patients with intravenous patient-controlled analgesia (PCA) received ramosetron 0.3 mg plus dexamethasone 5 mg (group R + D) or ondansetron 4 mg plus dexamethasone 5 mg (group O + D) intravenously. Fentanyl-based PCA was administered for 48 hr postoperatively; ramosetron 0.3 mg or ondansetron 12 mg was added to the PCA regimen according to the allocated group. The incidence of PONV and rescue antiemetic were assessed for 48 hr postoperatively at 0-6, 6-24, and 24-48 hr.ResultsThe overall incidence of PONV did not differ between the groups (50% vs. 60%, in groups R + D and O + D, respectively). The overall incidence of nausea was similar between groups (47% vs. 60%, in groups R + D and O + D, respectively). The overall frequency of vomiting was also similar between groups (8% vs. 12%, in groups R + D and O + D, respectively). The severity of nausea and the overall use of rescue antiemetic were not different between groups.ConclusionsThe antiemetic efficacy of ramosetron plus dexamethasone was similar to that of ondansetron plus dexamethasone on preventing PONV in high-risk patients undergoing lumbar spinal surgery.
first_indexed 2024-12-13T11:36:09Z
format Article
id doaj.art-54476ce63b5f40feb53c72a0a8e79eb1
institution Directory Open Access Journal
issn 2005-6419
2005-7563
language English
last_indexed 2024-12-13T11:36:09Z
publishDate 2012-06-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj.art-54476ce63b5f40feb53c72a0a8e79eb12022-12-21T23:47:47ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632012-06-0162654354710.4097/kjae.2012.62.6.5437358Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunctYong Seon Choi0Jae-Kwang Shim1Seung-Ho Ahn2Young Lan Kwak3Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.BackgroundDespite the development of a new class of antiemetics, postoperative nausea and vomiting (PONV) still remains a frequent and distressing complication. We compared the prophylactic antiemetic effect of administering dexamethasone 5 mg as an adjunct to ramosetron and ondansetron in patients at high-risk for PONV following lumbar spinal surgery.MethodsIn this randomized, double-blind study, 120 female non-smoking patients with intravenous patient-controlled analgesia (PCA) received ramosetron 0.3 mg plus dexamethasone 5 mg (group R + D) or ondansetron 4 mg plus dexamethasone 5 mg (group O + D) intravenously. Fentanyl-based PCA was administered for 48 hr postoperatively; ramosetron 0.3 mg or ondansetron 12 mg was added to the PCA regimen according to the allocated group. The incidence of PONV and rescue antiemetic were assessed for 48 hr postoperatively at 0-6, 6-24, and 24-48 hr.ResultsThe overall incidence of PONV did not differ between the groups (50% vs. 60%, in groups R + D and O + D, respectively). The overall incidence of nausea was similar between groups (47% vs. 60%, in groups R + D and O + D, respectively). The overall frequency of vomiting was also similar between groups (8% vs. 12%, in groups R + D and O + D, respectively). The severity of nausea and the overall use of rescue antiemetic were not different between groups.ConclusionsThe antiemetic efficacy of ramosetron plus dexamethasone was similar to that of ondansetron plus dexamethasone on preventing PONV in high-risk patients undergoing lumbar spinal surgery.http://ekja.org/upload/pdf/kjae-62-543.pdfdexamethasoneondansetronpostoperative nausea and vomitingramosetron
spellingShingle Yong Seon Choi
Jae-Kwang Shim
Seung-Ho Ahn
Young Lan Kwak
Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
Korean Journal of Anesthesiology
dexamethasone
ondansetron
postoperative nausea and vomiting
ramosetron
title Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
title_full Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
title_fullStr Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
title_full_unstemmed Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
title_short Efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high-risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
title_sort efficacy comparison of ramosetron with ondansetron on preventing nausea and vomiting in high risk patients following spine surgery with a single bolus of dexamethasone as an adjunct
topic dexamethasone
ondansetron
postoperative nausea and vomiting
ramosetron
url http://ekja.org/upload/pdf/kjae-62-543.pdf
work_keys_str_mv AT yongseonchoi efficacycomparisonoframosetronwithondansetrononpreventingnauseaandvomitinginhighriskpatientsfollowingspinesurgerywithasinglebolusofdexamethasoneasanadjunct
AT jaekwangshim efficacycomparisonoframosetronwithondansetrononpreventingnauseaandvomitinginhighriskpatientsfollowingspinesurgerywithasinglebolusofdexamethasoneasanadjunct
AT seunghoahn efficacycomparisonoframosetronwithondansetrononpreventingnauseaandvomitinginhighriskpatientsfollowingspinesurgerywithasinglebolusofdexamethasoneasanadjunct
AT younglankwak efficacycomparisonoframosetronwithondansetrononpreventingnauseaandvomitinginhighriskpatientsfollowingspinesurgerywithasinglebolusofdexamethasoneasanadjunct